Longitudinal Cognitive Assessment by BoCA
Launched by ALZHEIMER'S LIGHT LLC · Oct 2, 2019
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
The Boston Cognitive Assessment (BoCA) trial is studying a new online test designed to help track thinking and memory skills over time in people with conditions like Alzheimer’s disease, mild cognitive impairment, and other neurological disorders. This test uses different tasks each time to ensure that participants don't just get better at it because they’ve practiced. The goal is to see how effective treatments are in helping with these conditions.
To participate in this trial, individuals need to be 50 years or older, as those younger than 50 are not eligible. Participants can expect to take the BoCA test online at their convenience, which will help researchers gather important information about cognitive changes over time. This trial is currently recruiting, so there are opportunities for anyone who meets the age requirement and is interested in contributing to our understanding of cognitive health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age 50 or older
- Exclusion Criteria:
- • younger than 50 years
About Alzheimer's Light Llc
Alzheimer's Light LLC is a dedicated clinical trial sponsor focused on advancing innovative therapeutic solutions for Alzheimer’s disease and related neurodegenerative disorders. With a commitment to improving patient outcomes, the company employs cutting-edge research methodologies and collaborates with leading academic institutions and healthcare providers. Alzheimer's Light LLC seeks to enhance understanding of Alzheimer’s pathology through rigorous clinical trials, ultimately aiming to bring effective therapies to market that can significantly impact the lives of patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials